Literature DB >> 23089275

Genetic disorders resulting in hyper- or hypouricemia.

Ivan Sebesta1.   

Abstract

Serum uric acid concentrations are governed by the balance of urate production and excretion. Besides well-known secondary causes of hyperuricemia, such as myeloproliferative diseases, decreased renal function, and excessive dietary purine intake, there are a number of genetic disorders that result in hyper- or hypouricemia. Renal impairment in these disorders may be associated with the development of chronic kidney disease, acute kidney injury, or urate nephrolithiasis. These conditions are frequently misdiagnosed, not because the diagnosis is complicated and difficult to ascertain, but rather because of a lack of awareness of the particular condition. The first important step in the diagnosis is obtaining a detailed family history, with evaluation of serum and urinary urate concentrations. This review will aid physicians in identifying these inherited kidney disorders associated with hyperuricemia and hypouricemia. Identification of these conditions will help to explain the pathogenesis of different types of gout, and may extend insights into the urate transport and chronic kidney disease.
Copyright © 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23089275     DOI: 10.1053/j.ackd.2012.06.002

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  9 in total

Review 1.  The crystallization of monosodium urate.

Authors:  Miguel A Martillo; Lama Nazzal; Daria B Crittenden
Journal:  Curr Rheumatol Rep       Date:  2014-02       Impact factor: 4.592

Review 2.  Hypouricemia: what the practicing rheumatologist should know about this condition.

Authors:  Carlos Pineda; Carina Soto-Fajardo; Jaime Mendoza; Jessica Gutiérrez; Hugo Sandoval
Journal:  Clin Rheumatol       Date:  2019-10-24       Impact factor: 2.980

3.  Genetic variation underlying renal uric acid excretion in Hispanic children: the Viva La Familia Study.

Authors:  Geetha Chittoor; Karin Haack; Nitesh R Mehta; Sandra Laston; Shelley A Cole; Anthony G Comuzzie; Nancy F Butte; V Saroja Voruganti
Journal:  BMC Med Genet       Date:  2017-01-17       Impact factor: 2.103

Review 4.  Biosensors Incorporating Bimetallic Nanoparticles.

Authors:  John Rick; Meng-Che Tsai; Bing Joe Hwang
Journal:  Nanomaterials (Basel)       Date:  2015-12-31       Impact factor: 5.076

5.  Multiple Subcutaneous Gouty Tophi Even with Appropriate Medical Treatment: Case Report and Review of Literature.

Authors:  Troy D Erickson; Binara Assylbekova; Alexander C M Chong
Journal:  Kans J Med       Date:  2021-01-21

Review 6.  The Role of Oxidative Stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors.

Authors:  Ning Liu; Hu Xu; Qianqian Sun; Xiaojuan Yu; Wentong Chen; Hongquan Wei; Jie Jiang; Youzhi Xu; Wenjie Lu
Journal:  Oxid Med Cell Longev       Date:  2021-03-26       Impact factor: 6.543

Review 7.  Clinical features of gout in adult patients with type Ia glycogen storage disease: a single-centre retrospective study and a review of literature.

Authors:  Na Xu; Xinxin Han; Yun Zhang; Xiaoming Huang; Weiguo Zhu; Min Shen; Wen Zhang; Chen Jialin; Min Wei; Zhengqing Qiu; Xuejun Zeng
Journal:  Arthritis Res Ther       Date:  2022-02-26       Impact factor: 5.156

Review 8.  Physiology of Hyperuricemia and Urate-Lowering Treatments.

Authors:  Caroline L Benn; Pinky Dua; Rachel Gurrell; Peter Loudon; Andrew Pike; R Ian Storer; Ciara Vangjeli
Journal:  Front Med (Lausanne)       Date:  2018-05-31

Review 9.  Renal effects of uric acid: hyperuricemia and hypouricemia.

Authors:  Jung Hwan Park; Yong-Il Jo; Jong-Ho Lee
Journal:  Korean J Intern Med       Date:  2020-09-09       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.